Skip to content
10-Q

Quarterly Report

JINZANGHUANG TIBET PHARMACEUTICALS, INC.

0001096906-13-000206

← back to feed
Filed
Feb 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Feb 13, 2013 50.67M sh
Operating Cash Flow Q2 2013 · Dec 31, 2012 $4.1M
Operating Cash Flow Q2 2013 · Dec 31, 2011 $2.97M
Stockholders Equity Q2 2013 · Dec 31, 2012 $14.11M
Stockholders Equity Q2 2013 · Jun 30, 2012 $8.99M
Total Liabilities Q2 2013 · Dec 31, 2012 $945.3K
Total Liabilities Q2 2013 · Jun 30, 2012 $632.3K
Current Assets Q2 2013 · Dec 31, 2012 $15.16M
Current Assets Q2 2013 · Jun 30, 2012 $9.5M
Total Assets Q2 2013 · Dec 31, 2012 $15.74M
Total Assets Q2 2013 · Jun 30, 2012 $10.09M
Sga Expense Q2 2013 · Dec 31, 2012 $90.93K
Sga Expense Q2 2013 · Dec 31, 2012 $161.59K
Sga Expense Q2 2013 · Dec 31, 2011 $72.51K
Sga Expense Q2 2013 · Dec 31, 2011 $187.15K
Net Income Q2 2013 · Dec 31, 2012 $2.2M
Net Income Q2 2013 · Dec 31, 2012 $4.04M
Net Income Q2 2013 · Dec 31, 2011 $1.53M
Net Income Q2 2013 · Dec 31, 2011 $3.06M
Operating Income Q2 2013 · Dec 31, 2012 $3.09M
Operating Income Q2 2013 · Dec 31, 2012 $5.66M
Operating Income Q2 2013 · Dec 31, 2011 $2M
Operating Income Q2 2013 · Dec 31, 2011 $4.08M
Gross Profit Q2 2013 · Dec 31, 2012 $3.19M
Gross Profit Q2 2013 · Dec 31, 2012 $5.82M
Gross Profit Q2 2013 · Dec 31, 2011 $2.07M
Gross Profit Q2 2013 · Dec 31, 2011 $4.27M
Cost Of Revenue Q2 2013 · Dec 31, 2012 $859.27K
Cost Of Revenue Q2 2013 · Dec 31, 2012 $1.56M
Cost Of Revenue Q2 2013 · Dec 31, 2011 $590.18K
Cost Of Revenue Q2 2013 · Dec 31, 2011 $953.32K
Revenue Q2 2013 · Dec 31, 2012 $4.04M
Revenue Q2 2013 · Dec 31, 2012 $7.38M
Revenue Q2 2013 · Dec 31, 2011 $2.66M
Revenue Q2 2013 · Dec 31, 2011 $5.22M